GeneDx Holdings Corp (NASDAQ: WGS) established initial surge of 3.42% at $99.13, as the Stock market unbolted on Wednesday, before settling in for the price of $95.85 at the close. Taking a more long-term approach, WGS posted a 52-week range of $7.56-$115.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 16.51% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 96.65%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 248.68%. This publicly-traded company’s shares outstanding now amounts to $28.02 million, simultaneously with a float of $24.14 million. The organization now has a market capitalization sitting at $2.78 billion. At the time of writing, stock’s 50-day Moving Average stood at $79.86, while the 200-day Moving Average is $52.33.
GeneDx Holdings Corp (WGS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the GeneDx Holdings Corp industry. GeneDx Holdings Corp’s current insider ownership accounts for 14.00%, in contrast to 86.43% institutional ownership. Preceding that transaction, on Jan 29 ’25, Company’s CHIEF FINANCIAL OFFICER sold 275 for 78.48, making the whole transaction’s value amount to 21,582. This particular insider is now the holder of 2,950 in total.
GeneDx Holdings Corp (WGS) Earnings and Revenue Records
GeneDx Holdings Corp’s EPS increase for this current 12-month fiscal period is 248.68% and is forecasted to reach 1.89 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 119.03% through the next 5 years, which can be compared against the 96.65% growth it accomplished over the previous five years trading on the market.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
Let’s observe the current performance indicators for GeneDx Holdings Corp (WGS). It’s Quick Ratio in the last reported quarter now stands at 3.42. The Stock has managed to achieve an average true range (ATR) of 9.33. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.11.
In the same vein, WGS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.99, a figure that is expected to reach 0.08 in the next quarter, and analysts are predicting that it will be 1.89 at the market close of one year from today.
Technical Analysis of GeneDx Holdings Corp (WGS)
Now, what If we examine the latest scores posted by [GeneDx Holdings Corp, WGS]. During the last 5-days, its volume was lower the volume of 1.25 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 61.16% While, its Average True Range was 9.94.
Raw Stochastic average of GeneDx Holdings Corp (WGS) in the period of the previous 100 days is set at 77.56%, which indicates a major rise in contrast to 71.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 185.10% that was higher than 116.83% volatility it exhibited in the past 100-days period.
